Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
about
The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteinsUpregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotypeMelanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cellsCirculating serologic and molecular biomarkers in malignant melanomaUltrastructural cartilage abnormalities in MIA/CD-RAP-deficient miceBackbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains.Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.The secreted form of a melanocyte membrane-bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding.Diagnostic and prognostic biomarkers in melanoma.Prognostic value of melanoma inhibitory activity protein in localized cutaneous malignant melanomaGlycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.The expression of melanoma inhibitory activity on mast cells in child patients with cutaneous mastocytosis.Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinomaCo-modulation analysis of gene regulation in breast cancer reveals complex interplay between ESR1 and ERBB2 genesMelanoma inhibitory activity in Brazilian patients with cutaneous melanoma.Promoters with cancer cell-specific activity for melanoma gene therapy.GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma.Serum markers to detect metastatic uveal melanoma.Melanoma biomarkers: Vox clamantis in deserto (Review)Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma.Established and Emerging Biomarkers in Cutaneous Malignant Melanoma.S-100B concentrations predict disease-free survival in stage III melanoma patients.Biomarkers in melanoma.Methodology and applications of disease biomarker identification in human serum.Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma.Human melanoma inhibitory protein binds to the FN12-14 Hep II domain of fibronectin.Annexin VII as a novel marker for invasive phenotype of malignant melanoma.Small Molecules Antagonise the MIA-Fibronectin Interaction in Malignant Melanoma.Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood.Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice.Anorectal mucosal melanoma.
P2860
Q24536791-364C2588-9D64-4CAB-8A7E-9BB4C9E540F6Q24598268-C58868EB-5A06-4BBF-9073-0FBF0BEB99CAQ24685044-39E6DAE8-1C87-4A07-A99B-A324C277BBC4Q24796817-D45D4EF7-7A73-4F2B-9525-F0BB6EB31A28Q27020946-A7134E96-3596-4273-BA0F-9E0C0AF9D1E4Q28591920-73C09654-4EA6-49A3-B883-AE88E67126D2Q30164886-809B3314-FCEC-400E-9304-97C95F925F78Q30481818-9019319B-7141-4216-9DE3-228D839C8B29Q33694588-25498374-29A3-4F4F-BC8D-052DD01594C4Q33862470-C9BAC709-C453-4A2E-9692-01BCB972A85FQ33876332-A699F68D-B354-45EC-9CC0-77AE18803DF7Q33891014-E5912AA1-35D2-443A-AF1B-1A2CC6763FB0Q34403961-60578A47-9FC2-4317-A890-5F1169220834Q34482255-3C71D4D9-2FB4-4983-9DA3-9BE604E73ACCQ34524975-3196550A-01E1-45CE-86C4-00E5FF068574Q35671323-C4833328-F295-4076-B855-B09CD2285BCAQ35892166-76159F87-BC91-453D-B93A-22DF03CC6A4AQ35944371-F7B9A3DD-E8A6-4FE4-8492-9FDA7E4FF924Q35959897-27993CDF-EB35-4DF8-A200-90D97C37A36DQ36003100-3EFA9977-B22B-40CB-BF35-F1EEE1EF82F8Q36216949-52FE6A90-B3D3-4B57-AAD5-EEA248899630Q36707344-00400787-5117-4EFF-A07A-05E79B08D125Q37061845-063BD783-2579-492B-9EF0-CCB326BD7B1BQ37069223-A8801697-E6BE-4F5E-9BB3-85AEE54255AFQ37425922-97067659-E054-43C4-A2F0-08C9AA557008Q37555801-346092B1-E200-44CC-BB83-C7CD08B5DEA7Q37574961-1D747368-9DC4-461D-B083-876FBAB731C7Q37775417-E32CBB17-EC69-4C22-8651-558FDFA3A0B8Q38110273-4E976284-64B8-48CB-A990-C8EBD37A9FE6Q38676582-4D144C72-5A0D-4364-AB72-609C45589831Q40890223-66A673A4-CF96-4D8D-A4D5-ABF251D676FFQ41085432-B6CF2937-2D4A-4BB8-B778-F8C24AECFF52Q43201983-0FA73C54-A928-405E-9049-D27CEEEFF658Q43202501-11A3B0CA-9D99-401B-80F3-189CFA6787C6Q51224682-D907A890-5EBC-4873-838C-2BC45E29FD00Q52680468-B4DBB23D-C8F0-44E0-9574-115CC487CFB3
P2860
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@ast
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@en
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@nl
type
label
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@ast
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@en
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@nl
prefLabel
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@ast
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@en
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@nl
P2093
P3181
P1433
P1476
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
@en
P2093
H Zirngibl
M Kaufmann
R Buettner
P304
P3181
P407
P577
1997-08-01T00:00:00Z